Aurisco Pharmaceutical Co.,Ltd. (605116.SS) SHH

Currency In CNY

AD

Valuation

Market Cap10.05B
Enterprise Value10.29B
P/E Ratio20.77
PEG Ratio-2.57
Price/Sales Ratio4.51
Price/Book Ratio2.87
Enterprise/Revenue4.73
Enterprise/EBITDA13.77

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.22
Operating Margin0.27
AD

Management Effectiveness

Return On Assets0.09
Return On Equity0.14

Income Statement

Revenue1.7B
Revenue/Share4.2
Gross Profit1.01B
EBITDA678.98M
Net Income449.21M
Diluted EPS1.1

Balance Sheet

Total Cash720.92M
Total Cash/Share1.78
Total Debt1.03B
Total Debt/Equity0.38
Current Ratio4.16
Book Value Per Share6.84

Price History

52-Week Change-18
52-Week High35.58
52-Week Low18.09
Moving Average 50 Days19.98
Moving Average 200 Days23.48

Statistics

Average Volume3.84M
Shares Outstanding406.18M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.34
Trailing Annual Dividend Yield1.8
Payout Ratio0.38
Last Split FactorN/A
Last Split DateN/A
AD